oritavancin (Q7102878)

From Wikidata

Jump to navigation Jump to search

pharmaceutical drug

LY-333328
Chlorobiphenyl-chloroeremomycin
Oritavancin

Language	Label	Description	Also known as
English	oritavancin	pharmaceutical drug	LY-333328 Chlorobiphenyl-chloroeremomycin Oritavancin

Statements

type of chemical entity

0 references

lipoglycopeptides

1 reference

27 February 2018

1 reference

Oritavancin (English)

language of work or name

publication date

17 November 2015

1,790.564106 dalton

1 reference

language of work or name

Oritavancin (English)

21 September 2016

chemical formula

C₈₆H₉₇Cl₃N₁₀O₂₆

1 reference

language of work or name

Oritavancin (English)

18 November 2016

canonical SMILES

CC1C(C(CC(O1)OC2C3C(=O)NC(C4=CC(=CC(=C4C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C(C=C8)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C2C=C1)Cl)O)O)O)C(=O)O)(C)N)O

1 reference

language of work or name

Oritavancin (English)

18 November 2016

isomeric SMILES

CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC(Cl)=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]5C[C@](C)(NCC6=CC=C(C=C6)C7=CC=C(Cl)C=C7)[C@@H](O)[C@H](C)O5)C8=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]9C%10=CC=C(O)C(=C%10)C%11=C(C=C(O)C=C%11O)[C@H](NC(=O)[C@@H](NC9=O)[C@H](O[C@H]%12C[C@](C)(N)[C@@H](O)[C@H](C)O%12)C%13=CC(Cl)=C(O8)C=C%13)C(O)=O)C=C2

1 reference

Global Substance Registration System

14 February 2018

active ingredient in

1 reference

14 February 2018

medical condition treated

1 reference

Drug Indications Extracted from FAERS

2 October 2018

subject has role

protein synthesis inhibitor

1 reference

5 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

1 reference

‎WHO Aware Classification

1 reference

2023 ‎AWaRe classification‎

Identifiers

InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1

1 reference

based on heuristic

inferred from SMILES

VHFGEBVPHAGQPI-LXKZPTCJSA-N

2 references

language of work or name

Oritavancin (English)

18 November 2016

Global Substance Registration System

14 February 2018

CAS Registry Number

3 references

language of work or name

Oritavancin (English)

18 November 2016

Global Substance Registration System

14 February 2018

VHFGEBVPHAGQPI-LXKZPTCJSA-N

CAS Common Chemistry

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=171099-57-3

1 reference

language of work or name

(1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-Amino-2-oxoethyl)-2-[(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-arabino-hexopyranosyl)oxy]-5,15-dichloro-48-{[2-O-(3-{[(4'-chloro-4-biphenylyl)methyl]amino}-2,3,6-t (English)

18 November 2016

2 references

language of work or name

Oritavancin (English)

18 November 2016

matched by identifier from

VHFGEBVPHAGQPI-LXKZPTCJSA-N

1 reference

matched by identifier from

VHFGEBVPHAGQPI-LXKZPTCJSA-N

mapping relation type

3 references

language of work or name

ORITAVANCIN (English)

18 November 2016

ChEBI release 2021-03-01

matched by identifier from

International Chemical Identifier

InChI=1S/C86H97Cl3N10O26/c1-35(2)22-51(92-7)77(110)98-67-69(105)42-15-20-55(49(88)24-42)120-57-26-44-27-58(73(57)125-84-74(71(107)70(106)59(34-100)122-84)124-62-32-86(6,76(109)37(4)119-62)93-33-38-8-10-39(11-9-38)40-12-17-45(87)18-13-40)121-56-21-16-43(25-50(56)89)72(123-61-31-85(5,91)75(108)36(3)118-61)68-82(115)97-66(83(116)117)48-28-46(101)29-54(103)63(48)47-23-41(14-19-53(47)102)64(79(112)99-68)96-80(113)65(44)95-78(111)52(30-60(90)104)94-81(67)114/h8-21,23-29,35-37,51-52,59,61-62,64-72,74-76,84,92-93,100-103,105-109H,22,30-34,91H2,1-7H3,(H2,90,104)(H,94,114)(H,95,111)(H,96,113)(H,97,115)(H,98,110)(H,99,112)(H,116,117)/t36-,37-,51+,52-,59+,61-,62-,64+,65+,66-,67+,68-,69+,70+,71-,72+,74+,75-,76-,84-,85-,86-/m0/s1

1 reference

language of work or name

ORITAVANCIN (English)

18 November 2016

UniChem compound ID

1 reference

DSSTox substance ID

1 reference

matched by identifier from

VHFGEBVPHAGQPI-LXKZPTCJSA-N

DSSTOX compound identifier

DTXCID701326917

0 references

1 reference

language of work or name

Oritavancin (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

5 February 2021

MeSH descriptor ID

1 reference

Medical Subject Headings

MeSH descriptor ID

14 March 2018

1 reference

Global Substance Registration System

14 February 2018

1 reference

matched by identifier from

VHFGEBVPHAGQPI-LXKZPTCJSA-N

3 references

language of work or name

Oritavancin (English)

18 November 2016

Global Substance Registration System

14 February 2018

matched by identifier from

VHFGEBVPHAGQPI-LXKZPTCJSA-N

MedlinePlus drug identifier

0 references

1 reference

language of work or name

ORITAVANCIN (English)

19 January 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

Oritavancin (English)

19 January 2016

0 references

Microsoft Academic ID

0 references

WikiProjectMed ID

0 references

Sitelinks

Wikipedia(14 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q7102878&oldid=2186544671"